Astrazeneca (AZN) reported 13.57billioninrevenueforthequarterendedSeptember2024,representingayear−over−yearincreaseof181.04 for the same period compares to 0.87ayearago.Thereportedrevenuerepresentsasurpriseof+4.0213.04 billion. With the consensus EPS estimate being $1.01, the EPS surprise was +2.97%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...